Skip to main content
. Author manuscript; available in PMC: 2014 Jul 3.
Published in final edited form as: J Neurosurg. 2013 Sep 27;119(6):1520–1529. doi: 10.3171/2013.8.JNS13969

Table 1. Treatment parameters, estimated in situ peak rarefaction pressures, and results of third ventriculostomies in 9 swine treated using the ExAblate 4000 MRIgFUS system.

Frequency
(kHz)
Acoustic
Power (W)
Simulated
(MPa)
dT/dt
(MPa)*
McDannold
(MPa)
Pulse Duration
(sec)
No. of
Pulses
Successful? Size
(mm)
Vessel
Damage (mm)
Rim of
Damage (mm)
650 1000 27.5 15.7 15.0 0.1 1 yes 2.3 0.9 0.9
650 2200 29.8 17.0 16.2 0.1 2 no
650 1500 36.1 20.6 19.6 0.3 3 no
650 1000 39.7 22.7 21.6 1 1 yes 6.6 0.6 0.6
650 2000 44.7 25.5 24.4 1 1 yes 9.2 1.5 0.7
650 2000 47.0 26.8 25.6 1 1 yes 9.3 0.4 0.4
650 1500 50.4 28.8 27.4 1 1 yes 8.5 1 0.6
650 1900 20.6 11.8 11.2 5 1 no
230 2900 16.3 9.3 8.8 1 1 yes 4.7 3.2 0.7
*

The error was estimated to be ± 9% without skull and ± 22% with skull. This method extended to 230 kHz assumed a gain proportional to frequency. The error was attributable to the uncertainty in the physical parameters used in the model, as well as the measurement error in skull transmission.

The calibration error was reported to be ± 10%,21 leading to an estimate of ± 24% for our measurements. The increased error is due to the combination of uncertainty in the transmission through skull, the attenuation of brain tissue, and the intensity loss due to steering. This method extended to 650 kHz similarly assumed an increased gain proportional to the frequency.